Potential biomarker emerging for diabetic neuropathy

June 13, 2012
Nervous system

An emerging biomarker may eventually lead to new approaches for treating diabetics at risk of developing nerve damage, UNSW researchers have found.

The researchers say neuropathy in is under-diagnosed and early identification has been problematic. It is estimated that up to 50 per cent of diabetics end up with nerve damage.

They tested excitability in diabetics with and without neuropathy and found those without irreversible still showed excitability abnormalities well before the development of clinical symptoms.

“Excitability testing provides a to identify the early development and severity of diabetic neuropathy,” the key researcher Dr Cindy Lin said.

The research was led by UNSW and the School of Medical Science’s Dr Cindy Lin and is published in the journal Diabetes.

Professor Matthew Kiernan from UNSW says the research may lead to new therapeutic approaches for treating patients with diabetic neuropathy early.

“It may yet prove possible to initiate therapy in diabetic patients well before they manifest the neurological symptoms and disability that inevitably reflects the presence clinical neuropathy,” Professor Kiernan says in his commentary, also published in Diabetes.

“Pharmacological manipulation of axonal membrane channels seems likely to provide further new therapeutic approaches for treating patients with diabetic neuropathy,” he says.

Explore further: To fix diabetic nerve damage, blood vessels and support cells may be the real targets of treatment

Related Stories

Recommended for you

How does friendly fire happen in the pancreas?

October 21, 2016

In type 1 diabetes, the body attacks its own insulin-producing cells. Scientists at Helmholtz Zentrum München, partner in the German Center for Diabetes Research, and their colleagues at Technical University of Munich have ...

Diabetes opens floodgates to fructose

October 11, 2016

Fructose, once seen as diabetics' alternative to glucose, is fast-tracked to the liver in diabetic mice and contributes to metabolic diseases, according to new research from Harvard University.

Type 2 diabetes and obesity—what do we really know?

October 6, 2016

Social and economic factors have led to a dramatic rise in type 2 diabetes and obesity around the world. In a review in Science, Mark McCarthy, professor at the University of Oxford, UK, and Paul Franks, professor at Lund ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.